These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34640490)

  • 1. Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study.
    Labuz-Roszak B; Banach M; Skrzypek M; Windak A; Tomasik T; Mastej M; Tomaszewski M; Mikhailidis DP; Toth PP; Catapano A; Ray KK; Howard G; Lip GYH; Charchar FJ; Sattar N; Williams B; MacDonald TM; Penson P; Jozwiak JJ; On Behalf Of The Lipidogram Investigators
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary prevention of stroke in elderly people in Poland--results of PolSenior study.
    Labuz-Roszak B; Skrzypek M; Pierzchała K; Machowska-Majchrzak A; Mossakowska M; Chudek J; Mańka-Gaca I; Bartman W; Więcek A
    Neurol Neurochir Pol; 2014; 48(2):85-90. PubMed ID: 24821632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet and anticoagulant therapy in elderly people with type 2 diabetes mellitus in Poland (based on the PolSenior Study).
    Łabuz-Roszak B; Machowska-Majchrzak A; Skrzypek M; Mossakowska M; Chudek J; Więcek A; Wawrzyńczyk M; Łącka-Gaździk B; Pierzchała K
    Arch Med Sci; 2017 Aug; 13(5):1018-1024. PubMed ID: 28883841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological stroke prevention in the elderly with atrial fibrillation in Poland - Results of PolSenior study.
    Łabuz-Roszak B; Skrzypek M; Machowska-Majchrzak A; Mossakowska M; Chudek J; Więcek A; Pierzchała K; Łącka-Gaździk B; Grodzicki T
    Neurol Neurochir Pol; 2017; 51(5):382-387. PubMed ID: 28756016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.
    RAF and RENO-EXTEND Investigators*
    Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
    Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.
    Hankey GJ; Eikelboom JW; Yi Q; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R;
    Lancet Neurol; 2012 Jun; 11(6):512-20. PubMed ID: 22554931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland.
    Labuz-Roszak B; Pierzchala K; Skrzypek M; Swiech M; Machowska-Majchrzak A
    BMC Cardiovasc Disord; 2012 Oct; 12():98. PubMed ID: 23114009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin: its clinical role in cerebrovascular prevention.
    Gaspardone A; Arca M
    Drugs; 2007; 67 Suppl 1():55-62. PubMed ID: 17910521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of cardiovascular events in elderly people.
    Andrawes WF; Bussy C; Belmin J
    Drugs Aging; 2005; 22(10):859-76. PubMed ID: 16245959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC; Dwivedi G
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003186. PubMed ID: 22161375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antiplatelet drugs in the prevention of cardiovascular events.
    Tendera M; Wojakowski W
    Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in Secondary Prevention between Stroke and Coronary Heart Disease in China: Cross-Sectional Community-Based Study, 2014-2016.
    Xia S; Wang C; Du X; Guo L; Du J; Zheng Y; Wu S; Guang X; Zhou X; Lin H; Cheng X; Anderson CS; Huffman MD; Dong J; Yuan Y; Ma C
    Cerebrovasc Dis; 2022; 51(3):384-393. PubMed ID: 34879381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
    Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.